Crescent Acq.  CRSAU = 1C, 1/2W

424B4 March 11, 2019

based on the fair value of investment securities held in our Trust Account of approximately $253,760,110.55 as of July 15, 2020, the estimated per share redemption price would have been approximately $10.15

Trust $287.5 million if the underwriters’ over-allotment option is exercised in full ($10.00 per unit),

Trust shares 28.75 million.

Warrant 1 + $11.50. Call 18.  See adjust below. 

Crescent Capital

Credit Suisse -  BofA Merrill Lynch
I-Bankers Securities, Inc.

​In addition, if (x) we issue additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination, excluding any issuance of securities under the forward purchase agreement, at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by our board of directors and, in the case of any such issuance to our sponsor or its affiliates, without taking into account any founder shares held by our sponsor or such affiliates, as applicable, prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination, and (z) the volume weighted average trading price of our Class A common stock during the 10 trading day period starting on the trading day after the day on which we consummate our initial business combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the Market Value, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the Market Value.